Latest / Seattle News Today | 2 Min News | The Daily News Now!
New Pill Offers Hope for Pancreatic Cancer | Seattle News
FDA just approved a groundbreaking new pill for advanced pancreatic cancer — daraxonrasib — offering patients who’ve exhausted chemo a real lifeline. Targeting the mutated protein behind 90% of pancreatic tumors, it’s not a cure but has dramatically extended survival: median over 13 months vs. under 7 with chemo. Some patients have lived years. Doctors call it “life-altering.” Though costly — $39,800/month — hope is rising as insurers aim to cover most. This approval shifts the conversation on one of medicine’s toughest cancers. Listen in comfort:Get a discount on a Soli Pillow…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.